Literature DB >> 25541441

In vivo study of the mucus-permeating properties of PEG-coated nanoparticles following oral administration.

Laura Inchaurraga1, Nekane Martín-Arbella1, Virginia Zabaleta1, Gemma Quincoces2, Ivan Peñuelas2, Juan M Irache3.   

Abstract

The aim of this work was to investigate the mucus-permeating properties of poly(ethyleneglycol)-coated nanoparticles prepared from the copolymer of methyl vinyl ether and maleic anhydride (Gantrez® AN) after oral administration in rats. Nanoparticles were "decorated" with PEGs of different molecular masses (PEG2000, PEG6000 and PEG10000) at a PEG-to-polymer ratio of 0.125. All the PEG-coated nanoparticles displayed a mean size of ∼150 nm, slightly negative ζ values and a "brush" conformation as determined from the calculation of the PEG density. For in vivo studies, nanoparticles were labelled with either (99m)Tc or fluorescent tags. Naked nanoparticles displayed a higher ability to interact with the mucosa of the stomach than with the small intestine. However, these interactions were restricted to the mucus layer covering the epithelial surface, as visualised by fluorescence microscopy. On the contrary, PEG-coated nanoparticles moved rapidly to the intestine, as determined by imaging, and, then, were capable to develop important interactions with the mucosa, reaching the surface of the epithelium. These mucus permeating properties were more intense for nanoparticles coated with PEG2000 or PEG6000 than with PEG10000. However, the capability of nanocarriers to develop adhesive interactions within the mucosa decreased when prepared at excessive PEG densities.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Mucosa; Mucus; Nanoparticles; Oral; Poly(ethyleneglycol); Poly(methyl vinyl ether-co-maleic anhydride)

Mesh:

Substances:

Year:  2014        PMID: 25541441     DOI: 10.1016/j.ejpb.2014.12.021

Source DB:  PubMed          Journal:  Eur J Pharm Biopharm        ISSN: 0939-6411            Impact factor:   5.571


  10 in total

1.  Tuning the PEG surface density of the PEG-PGA enveloped Octaarginine-peptide Nanocomplexes.

Authors:  Eleni Samaridou; Nikolaos Kalamidas; Irene Santalices; José Crecente-Campo; Maria José Alonso
Journal:  Drug Deliv Transl Res       Date:  2020-02       Impact factor: 4.617

Review 2.  PEGylation as a strategy for improving nanoparticle-based drug and gene delivery.

Authors:  Jung Soo Suk; Qingguo Xu; Namho Kim; Justin Hanes; Laura M Ensign
Journal:  Adv Drug Deliv Rev       Date:  2015-10-09       Impact factor: 15.470

3.  Zein-based nanocarriers for the oral delivery of insulin. In vivo evaluation in Caenorhabditis elegans.

Authors:  Ana L Martínez-López; Carlos J González-Navarro; José L Vizmanos; Juan M Irache
Journal:  Drug Deliv Transl Res       Date:  2021-01-29       Impact factor: 4.617

4.  In vivo testing of mucus-permeating nanoparticles for oral insulin delivery using Caenorhabditis elegans as a model under hyperglycemic conditions.

Authors:  Ana L Martínez-López; Carlos J González-Navarro; Paula Aranaz; José L Vizmanos; Juan M Irache
Journal:  Acta Pharm Sin B       Date:  2021-03-01       Impact factor: 11.413

Review 5.  Surface Modified Multifunctional and Stimuli Responsive Nanoparticles for Drug Targeting: Current Status and Uses.

Authors:  Panoraia I Siafaka; Neslihan Üstündağ Okur; Evangelos Karavas; Dimitrios N Bikiaris
Journal:  Int J Mol Sci       Date:  2016-08-31       Impact factor: 5.923

Review 6.  Multifunctional oral delivery systems for enhanced bioavailability of therapeutic peptides/proteins.

Authors:  Ying Han; Zhonggao Gao; Liqing Chen; Lin Kang; Wei Huang; Mingji Jin; Qiming Wang; You Han Bae
Journal:  Acta Pharm Sin B       Date:  2019-01-10       Impact factor: 11.413

7.  OCTN2-targeted nanoparticles for oral delivery of paclitaxel: differential impact of the polyethylene glycol linker size on drug delivery in vitro, in situ, and in vivo.

Authors:  Longfa Kou; Rui Sun; Shuyi Xiao; Xiao Cui; Jin Sun; Vadivel Ganapathy; Qing Yao; Ruijie Chen
Journal:  Drug Deliv       Date:  2020-12       Impact factor: 6.419

8.  Monitoring the Fate of Orally Administered PLGA Nanoformulation for Local Delivery of Therapeutic Drugs.

Authors:  Lucia Morelli; Sara Gimondi; Marta Sevieri; Lucia Salvioni; Maria Guizzetti; Barbara Colzani; Luca Palugan; Anastasia Foppoli; Laura Talamini; Lavinia Morosi; Massimo Zucchetti; Martina Bruna Violatto; Luca Russo; Mario Salmona; Davide Prosperi; Miriam Colombo; Paolo Bigini
Journal:  Pharmaceutics       Date:  2019-12-06       Impact factor: 6.321

Review 9.  Interactions between Nanoparticles and Intestine.

Authors:  Manuela Vitulo; Elisa Gnodi; Raffaella Meneveri; Donatella Barisani
Journal:  Int J Mol Sci       Date:  2022-04-14       Impact factor: 6.208

10.  Memantine loaded PLGA PEGylated nanoparticles for Alzheimer's disease: in vitro and in vivo characterization.

Authors:  Elena Sánchez-López; Miren Ettcheto; Maria Antonia Egea; Marta Espina; Amanda Cano; Ana Cristina Calpena; Antoni Camins; Nuria Carmona; Amélia M Silva; Eliana B Souto; Maria Luisa García
Journal:  J Nanobiotechnology       Date:  2018-03-27       Impact factor: 10.435

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.